302 related articles for article (PubMed ID: 30026011)
21. CB1 Cannabinoid Agonist (WIN55,212-2) Within the Basolateral Amygdala Induced Sensitization to Morphine and Increased the Level of μ-Opioid Receptor and c-fos in the Nucleus Accumbens.
Molaei M; Fatahi Z; Zaringhalam J; Haghparast A
J Mol Neurosci; 2016 Apr; 58(4):446-55. PubMed ID: 26803309
[TBL] [Abstract][Full Text] [Related]
22. Pharmacological activation of CB1 receptor modulates long term potentiation by interfering with protein synthesis.
Navakkode S; Korte M
Neuropharmacology; 2014 Apr; 79():525-33. PubMed ID: 24412673
[TBL] [Abstract][Full Text] [Related]
23. Involvement of cannabinoid receptors in the amygdala and prefrontal cortex of rats in fear learning, consolidation, retrieval and extinction.
Kuhnert S; Meyer C; Koch M
Behav Brain Res; 2013 Aug; 250():274-84. PubMed ID: 23702112
[TBL] [Abstract][Full Text] [Related]
24. Endocannabinoid modulating drugs improve anxiety but not the expression of conditioned fear in a rodent model of post-traumatic stress disorder.
Vimalanathan A; Gidyk DC; Diwan M; Gouveia FV; Lipsman N; Giacobbe P; Nobrega JN; Hamani C
Neuropharmacology; 2020 Apr; 166():107965. PubMed ID: 31962287
[TBL] [Abstract][Full Text] [Related]
25. Acute Stress Suppresses Synaptic Inhibition and Increases Anxiety via Endocannabinoid Release in the Basolateral Amygdala.
Di S; Itoga CA; Fisher MO; Solomonow J; Roltsch EA; Gilpin NW; Tasker JG
J Neurosci; 2016 Aug; 36(32):8461-70. PubMed ID: 27511017
[TBL] [Abstract][Full Text] [Related]
26. Type 1 cannabinoid receptor ligands display functional selectivity in a cell culture model of striatal medium spiny projection neurons.
Laprairie RB; Bagher AM; Kelly ME; Dupré DJ; Denovan-Wright EM
J Biol Chem; 2014 Sep; 289(36):24845-62. PubMed ID: 25037227
[TBL] [Abstract][Full Text] [Related]
27. Increased Contextual Fear Conditioning in iNOS Knockout Mice: Additional Evidence for the Involvement of Nitric Oxide in Stress-Related Disorders and Contribution of the Endocannabinoid System.
Lisboa SF; Gomes FV; Silva AL; Uliana DL; Camargo LH; Guimarães FS; Cunha FQ; Joca SR; Resstel LB
Int J Neuropsychopharmacol; 2015 Jan; 18(8):. PubMed ID: 25618404
[TBL] [Abstract][Full Text] [Related]
28. Cannabinoids reverse the effects of early stress on neurocognitive performance in adulthood.
Alteba S; Korem N; Akirav I
Learn Mem; 2016 Jul; 23(7):349-58. PubMed ID: 27317195
[TBL] [Abstract][Full Text] [Related]
29. Cannabinoids ameliorate impairments induced by chronic stress to synaptic plasticity and short-term memory.
Abush H; Akirav I
Neuropsychopharmacology; 2013 Jul; 38(8):1521-34. PubMed ID: 23426383
[TBL] [Abstract][Full Text] [Related]
30. WIN55,212-2 impairs non-associative recognition and spatial memory in rats via CB1 receptor stimulation.
Galanopoulos A; Polissidis A; Georgiadou G; Papadopoulou-Daifoti Z; Nomikos GG; Pitsikas N; Antoniou K
Pharmacol Biochem Behav; 2014 Sep; 124():58-66. PubMed ID: 24867078
[TBL] [Abstract][Full Text] [Related]
31. Training-Associated Emotional Arousal Shapes Endocannabinoid Modulation of Spatial Memory Retrieval in Rats.
Morena M; De Castro V; Gray JM; Palmery M; Trezza V; Roozendaal B; Hill MN; Campolongo P
J Neurosci; 2015 Oct; 35(41):13962-74. PubMed ID: 26468197
[TBL] [Abstract][Full Text] [Related]
32. Developmental differences in the effects of CB1/2R agonist WIN55212-2 on extinction of learned fear.
Bisby MA; Richardson R; Baker KD
Prog Neuropsychopharmacol Biol Psychiatry; 2020 Apr; 99():109834. PubMed ID: 31830508
[TBL] [Abstract][Full Text] [Related]
33. Blockade of dorsal hippocampal dopamine receptors inhibits state-dependent learning induced by cannabinoid receptor agonist in mice.
Zarrindast MR; Dorrani M; Lachinani R; Rezayof A
Neurosci Res; 2010 May; 67(1):25-32. PubMed ID: 20144666
[TBL] [Abstract][Full Text] [Related]
34. Bidirectional alterations of hippocampal cannabinoid 1 receptors and their endogenous ligands in a rat model of alcohol withdrawal and dependence.
Mitrirattanakul S; López-Valdés HE; Liang J; Matsuka Y; Mackie K; Faull KF; Spigelman I
Alcohol Clin Exp Res; 2007 May; 31(5):855-67. PubMed ID: 17386072
[TBL] [Abstract][Full Text] [Related]
35. Prolonged exposure to WIN55,212-2 causes downregulation of the CB1 receptor and the development of tolerance to its anticonvulsant effects in the hippocampal neuronal culture model of acquired epilepsy.
Blair RE; Deshpande LS; Sombati S; Elphick MR; Martin BR; DeLorenzo RJ
Neuropharmacology; 2009 Sep; 57(3):208-18. PubMed ID: 19540252
[TBL] [Abstract][Full Text] [Related]
36. Behavioral and neurochemical changes in mesostriatal dopaminergic regions of the rat after chronic administration of the cannabinoid receptor agonist WIN55,212-2.
Fanarioti E; Mavrikaki M; Panagis G; Mitsacos A; Nomikos GG; Giompres P
Int J Neuropsychopharmacol; 2014 Dec; 18(6):. PubMed ID: 25522428
[TBL] [Abstract][Full Text] [Related]
37. Basolateral Amygdala Cannabinoid CB1 Receptor Controls Formation and Elimination of Social Fear Memory.
Li M; Lv X; Li T; Cui C; Yang X; Peng X; Lei J; Yang J; Ren K; Luo G; Shi Y; Yao Y; Tian B; Zhang P
ACS Chem Neurosci; 2023 Oct; 14(19):3674-3685. PubMed ID: 37718490
[TBL] [Abstract][Full Text] [Related]
38. Cannabinoid receptor type 1 activation causes a water diuresis by inducing an acute central diabetes insipidus in mice.
Rein JL; Mackie K; Kleyman TR; Satlin LM
Am J Physiol Renal Physiol; 2024 Jun; 326(6):F917-F930. PubMed ID: 38634131
[TBL] [Abstract][Full Text] [Related]
39. Activation of cannabinoid CB1 and CB2 receptors suppresses neuropathic nociception evoked by the chemotherapeutic agent vincristine in rats.
Rahn EJ; Makriyannis A; Hohmann AG
Br J Pharmacol; 2007 Nov; 152(5):765-77. PubMed ID: 17572696
[TBL] [Abstract][Full Text] [Related]
40. Cannabinoid type 1 receptor ligands WIN 55,212-2 and AM 251 alter anxiety-like behaviors of marmoset monkeys in an open-field test.
Cagni P; Barros M
Behav Brain Res; 2013 Mar; 240():91-4. PubMed ID: 23183218
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
